secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncology Institute, Inc. (TOI)
CIK:        0001799191
Form:       8-K
Filed at:   2023-08-30T23:59:59+00:00
Accession:  0001799191-23-000040
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncology Institute authorizes up to 2M share repurchase at ≤$1.00; Deerfield consents
--------------------------------------------------------------------------------

- Board approved repurchase of up to 2M shares of common stock at price not exceeding $1.00 per share.
- Limited Consent with Deerfield permits repurchases on or before Sep 16, 2023 under same price cap.
- Repurchased shares will be returned to authorized but unissued status.
- Company not obligated to repurchase any shares; timing subject to market conditions.
- Limited Consent also grants one-time waiver of certain notice requirements under Facility Agreement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000040/0001799191-23-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1799191/000179919123000040/toi-20230830.htm
  HTML page:      https://secwatch.observer/filing/0001799191-23-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer